Literature DB >> 12647636

Helicobacter pylori and telomerase activity in intestinal metaplasia of the stomach.

Il Kwun Chung1, Kyu Yoon Hwang, In Ho Kim, Hong Soo Kim, Sang Heum Park, Moon Ho Lee, Chang Jin Kim, Sun Joo Kim.   

Abstract

BACKGROUND: Helicobacter pylori (H. pylori) has been considered a definitive carcinogen in gastric cancer. Telomerase is activated in gastric cancer and some premalignant gastric lesions, including intestinal metaplasia (IM). In this study, we evaluated the relationships of both H. pylori infection and telomerase activity with endoscopic and histologic features in IM. The effects of H. pylori eradication on endoscopic, histologic and biochemical changes were evaluated.
METHODS: Endoscopic biopsies were obtained from 43 patients with IM for rapid urease, histologic and telomerase tests. The endoscopic and histologic features, H. pylori infection and telomerase were assessed. After H. pylori eradication, 15 patients were re-evaluated and compared after 4 months.
RESULTS: Thirty-four (79.1%) patients were infected with H. pylori. The incidence of H. pylori infection was borderline correlated to the severity of IM (p = 0.076). Telomerase was elevated in eight (18.6%) patients. Telomerase tends to be high in subtype III and endoscopic grade III of IM. After H. pylori eradication, endoscopic extent (p = 0.039) and histologic severity (p = 0.074) showed improvements, and telomerase decreased significantly (p = 0.0001).
CONCLUSION: Our data suggest that telomerase is associated with the severity and extent of IM and that H. pylori eradication improves the endoscopic and histologic features in IM, and decreases telomerase activity. H. pylori eradication can be considered one of the methods to prevent gastric cancer in patients with H. pylori-infected IM. Further long-term and large-scaled study will be needed.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12647636      PMCID: PMC4531692          DOI: 10.3904/kjim.2002.17.4.227

Source DB:  PubMed          Journal:  Korean J Intern Med        ISSN: 1226-3303            Impact factor:   2.884


  28 in total

1.  Effect of Helicobacter pylori eradication on gastritis in relation to cagA: a prospective 1-year follow-up study.

Authors:  R W van der Hulst; A van der Ende; F W Dekker; F J Ten Kate; J F Weel; J J Keller; S P Kruizinga; J Dankert; G N Tytgat
Journal:  Gastroenterology       Date:  1997-07       Impact factor: 22.682

2.  The mucin histochemistry of normal and neoplastic gastric mucosa.

Authors:  R Lev
Journal:  Lab Invest       Date:  1965-12       Impact factor: 5.662

3.  Alterations of the apc gene in carcinoma cell-lines and precancerous lesions of the stomach.

Authors:  K Nishimura; H Yokozaki; K Haruma; G Kajiyama; E Tahara
Journal:  Int J Oncol       Date:  1995-09       Impact factor: 5.650

4.  Telomerase activity is detected in pancreatic cancer but not in benign tumors.

Authors:  E Hiyama; T Kodama; K Shinbara; T Iwao; M Itoh; K Hiyama; J W Shay; Y Matsuura; T Yokoyama
Journal:  Cancer Res       Date:  1997-01-15       Impact factor: 12.701

Review 5.  Intestinal metaplasia of the stomach. A status report.

Authors:  G N Stemmermann
Journal:  Cancer       Date:  1994-07-15       Impact factor: 6.860

6.  Helicobacter pylori in promotion of gastric carcinogenesis.

Authors:  M Rugge; M Cassaro; G Leandro; R Baffa; C Avellini; P Bufo; V Stracca; G Battaglia; A Fabiano; A Guerini; F Di Mario
Journal:  Dig Dis Sci       Date:  1996-05       Impact factor: 3.199

7.  Changes in the gastric mucosa following eradication of Helicobacter pylori.

Authors:  R M Genta; G M Lew; D Y Graham
Journal:  Mod Pathol       Date:  1993-05       Impact factor: 7.842

8.  Telomerase activity in small-cell and non-small-cell lung cancers.

Authors:  K Hiyama; E Hiyama; S Ishioka; M Yamakido; K Inai; A F Gazdar; M A Piatyszek; J W Shay
Journal:  J Natl Cancer Inst       Date:  1995-06-21       Impact factor: 13.506

9.  Improvement of gastric inflammation and resolution of epithelial damage one year after eradication of Helicobacter pylori.

Authors:  E M Witteman; M Mravunac; M J Becx; W P Hopman; J S Verschoor; G N Tytgat; R W de Koning
Journal:  J Clin Pathol       Date:  1995-03       Impact factor: 3.411

10.  Length of telomeric repeats in neuroblastoma: correlation with prognosis and other biological characteristics.

Authors:  E Hiyama; K Hiyama; T Yokoyama; T Ichikawa; Y Matsuura
Journal:  Jpn J Cancer Res       Date:  1992-02
View more
  3 in total

Review 1.  Helicobacter pylori eradication to prevent gastric cancer: underlying molecular and cellular mechanisms.

Authors:  Shingo Tsuji; Masahiko Tsujii; Hiroaki Murata; Tsutomu Nishida; Masato Komori; Masakazu Yasumaru; Shuji Ishii; Yoshiaki Sasayama; Sunao Kawano; Norio Hayashi
Journal:  World J Gastroenterol       Date:  2006-03-21       Impact factor: 5.742

2.  Replication of the results of genome-wide and candidate gene association studies on telomere length in a Korean population.

Authors:  Sook Kyung Do; Seung Soo Yoo; Yi Young Choi; Jin Eun Choi; Hyo-Sung Jeon; Won Kee Lee; Shin Yup Lee; Jaehee Lee; Seung Ick Cha; Chang Ho Kim; Jae Yong Park
Journal:  Korean J Intern Med       Date:  2015-08-27       Impact factor: 2.884

3.  DNA Hypermethylation Downregulates Telomerase Reverse Transcriptase (TERT) during H. pylori-Induced Chronic Inflammation.

Authors:  Françoise I Bussière; Valérie Michel; Julien Fernandes; Lionel Costa; Vania Camilo; Giulia Nigro; Hilde De Reuse; Laurence Fiette; Eliette Touati
Journal:  J Oncol       Date:  2019-12-31       Impact factor: 4.375

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.